Founder, chairman and CEO of LDR Medical, a former portfolio company, Christophe led the strong growth of the company from its creation in 2000 and its establishment in the United Sates to the successful IPO on the Nasdaq, followed by its sale for US$1.1 billion. Supported by Keensight Capital throughout this remarkable journey, he is very close to the teams and has perfect knowledge of Keensight Capital’s growth buyout strategy and the portfolio companies’ challenges.
Based in the US, Christophe will share his extensive expertise in the healthcare industry, his vision and his international experience as an entrepreneur with Keensight Capital’s Investment and Portfolio Performance Teams. He will play an active role in the portfolio value creation and sourcing process, as well as providing meaningful guidance to the CEOs.
Keensight Capital’s Operating Partners form part of its network of highly-recognized professionals in the Information Technology/Internet and Healthcare/Wellbeing industries – a network of entrepreneurs and
experts forged for over 20 years within the firm’s ecosystem.
Pierre Remy, Managing Partner at Keensight Capital, said:
“We are very proud that a well-known personality like Christophe has joined us. His outstanding experience is a tremendous asset to Keensight Capital’s teams and the talented managers of the portfolio companies. With its team of Operating Partners, Keensight Capital fills its ranks with close and talented professionals to implement its growth buyout strategy and create value for its investors.”
In 2000, Franco-American entrepreneur Christophe Lavigne founded LDR Medical, a world leader in next-generation spinal implant devices.
Supported by Keensight Capital since 2002, Christophe successfully managed the exceptional growth of his company right up to its IPO on the Nasdaq in October 2013 and through to its acquisition in 2016 by US group Zimmer-Biomet for US$1.1 billion. At that time, LDR had over 600 employees, more than 350 distributors and agents across the United States, revenues of approximately US$185 million and operations in more than 35 countries.
Based in Austin, Texas, Christophe is also a musician, songwriter and producer.
Keensight Capital, one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. For 20 years, Keensight Capital’s team of seasoned professionals has leveraged their knowledge of investment and growth industries to invest for the long term in profitable companies with high growth potential and revenues in the range of €15 million to €250 million.
Drawing on its expertise in the Information Technology/Internet and Healthcare/Wellbeing sectors, Keensight identifies the best investment opportunities in Europe and works closely with management teams to develop and achieve their strategic vision.